Steve Pakola, MD

Steve Pakola, MDSteve Pakola, MDSteve Pakola, MD
  • Home
  • About
  • In The News
  • Contact
  • Bibliography
  • More
    • Home
    • About
    • In The News
    • Contact
    • Bibliography

Steve Pakola, MD

Steve Pakola, MDSteve Pakola, MDSteve Pakola, MD
  • Home
  • About
  • In The News
  • Contact
  • Bibliography

In The News

  • REGENXBIO Announces First Patient Dosed in Phase IIb/III NAAVIGATE Trial of Surabgene Lomparvovec in Diabetic Retinopathy; Company to Receive $100 Million Milestone
  • Steve Pakola: The Physician Who Chose Discovery Over the Exam Room — and Never Looked Back
  • Steve Pakola and the Long Game of Gene Therapy
  • REGENXBIO Announces Positive Topline Results from Pivotal Phase III AFFINITY DUCHENNE® Study of RGX-202
  • REGENXBIO Announces Completion of Enrollment in Pivotal Trials of Subretinal Surabgene Lomparvovec for Wet AMD
  • REGENXBIO Announces Pivotal Program for Surabgene Lomparvovec in Diabetic Retinopathy












Copyright © 2026 Steve Pakola - All Rights Reserved.